4th Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act Patient Access - H.R.5801 - HELP Copays Act Issues pertaining to the creation of a Neuroscience Center of Excellence at FDA

LobbyistCovered position, as disclosed
LINDSEY GRACE ARNOLD —
HEATHER STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6000 (117th), S. 3427 (117th), S. 464 (117th), H.R. 2163 (117th), H.R. 5801 (117th)

Medicare/Medicaid MMM

Drug Pricing - H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act Drug Pricing - H.R. 19 & S. 2164 Lower Costs, More Cures Act of 2021 Drug Pricing - A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14. Drug Pricing and Medicare - H.R. 5376 Build Back Better Act

LobbyistCovered position, as disclosed
LINDSEY GRACE ARNOLD —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 19 (117th), S. 2164 (117th), S.Con.Res. 14 (117th), H.R. 5376 (117th), H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.